Skip to content
Screener

Palisade Bio, Inc. PALI Q2 2026 earnings

Reported August 10, 2026 · After market close

Revenue$500.0KIn line
EPS-$0.05Beat by $0.00
Revenue estimate$500.0K
EPS estimate-$0.05

Next report

Nov 9, 2026 (in 2 months)
Revenue estimate$465.3K
EPS estimate-$0.06

FAQ

When did Palisade Bio, Inc. report Q2 2026 earnings?
Palisade Bio, Inc. (PALI) reported Q2 2026 earnings on August 10, 2026 after market close.
What were Palisade Bio, Inc.'s Q2 2026 revenue and EPS?
Palisade Bio, Inc. reported revenue of $500.0K and eps of $-0.05 for Q2 2026.
Did Palisade Bio, Inc. beat estimates in Q2 2026?
Revenue beat the consensus estimate of $500.0K by -. EPS beat the consensus estimate of $-0.05 by $0.00.
How did Palisade Bio, Inc.'s Q2 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 91.4% from $-0.58.
Where can I find Palisade Bio, Inc.'s Q2 2026 SEC filings?
You can read the 8-K earnings release (0001357459-26-000017) and the 10-Q periodic report (0001357459-26-000016) directly on SEC EDGAR. The filing index links above go to sec.gov.